George M Church

InstitutionHarvard Medical School
AddressBoston
Massachusetts
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 8 Covid-19 publications, with a maximum of 1 publications in June 2020 and July 2020 and Spetember 2020 and October 2020 and November 2020 and January 2021 and March 2021 and August 2021
    All Publications
    Bar chart showing 307 publications over 20 distinct years, with a maximum of 31 publications in 2013
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Zaki MM, Lesha E, Said K, Kiaee K, Robinson-McCarthy L, George H, Hanna A, Appleton E, Liu S, Ng AHM, Khoshakhlagh P, Church GM. Cell therapy strategies for COVID-19: Current approaches and potential applications. Sci Adv. 2021 Aug; 7(33). PMID: 34380619.
      Citations: 2     Fields:    
    2. Ter-Ovanesyan D, Gilboa T, Lazarovits R, Rosenthal A, Yu X, Li JZ, Church GM, Walt DR. Ultrasensitive Measurement of Both SARS-CoV-2 RNA and Antibodies from Saliva. Anal Chem. 2021 04 06; 93(13):5365-5370. PMID: 33755419.
      Citations: 4     Fields:    Translation:Humans
    3. Robinson-McCarthy LR, Mijalis AJ, Filsinger GT, de Puig H, Donghia NM, Schaus TE, Rasmussen RA, Ferreira R, Lunshof JE, Chao G, Ter-Ovanesyan D, Dodd O, Kuru E, Sesay AM, Rainbow J, Pawlowski AC, Wannier TM, Yin P, Collins JJ, Ingber DE, Church GM, Tam JM. Anomalous COVID-19 tests hinder researchers. Science. 2021 01 15; 371(6526):244-245. PMID: 33446547.
      Citations: 4     Fields:    Translation:Humans
    4. Chatterjee P, Ponnapati M, Kramme C, Plesa AM, Church GM, Jacobson JM. Targeted intracellular degradation of SARS-CoV-2 via computationally optimized peptide fusions. Commun Biol. 2020 11 23; 3(1):715. PMID: 33230174.
      Citations: 4     Translation:HumansCellsPHPublic Health
    5. Venkatakrishnan AJ, Kayal N, Anand P, Badley AD, Church GM, Soundararajan V. Benchmarking evolutionary tinkering underlying human-viral molecular mimicry shows multiple host pulmonary-arterial peptides mimicked by SARS-CoV-2. Cell Death Discov. 2020; 6(1):96. PMID: 33024578.
      Citations: 10     
    6. MacKay MJ, Hooker AC, Afshinnekoo E, Salit M, Kelly J, Feldstein JV, Haft N, Schenkel D, Nambi S, Cai Y, Zhang F, Church G, Church G, Dai J, Wang CL, Levy S, Huber J, Ji HP, Kriegel A, Wyllie AL, Mason CE. The COVID-19 XPRIZE and the need for scalable, fast, and widespread testing. Nat Biotechnol. 2020 09; 38(9):1021-1024. PMID: 32820257.
      Citations: 23     Fields:    Translation:HumansCellsPHPublic Health
    7. Eroshenko N, Gill T, Keaveney MK, Church GM, Trevejo JM, Rajaniemi H. Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures. Nat Biotechnol. 2020 07; 38(7):789-791. PMID: 32504046.
      Citations: 48     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    8. Hanley BP, Keen S, Church G, Church G. A Call for a Three-Tiered Pandemic Public Health Strategy in Context of SARS-CoV-2. Rejuvenation Res. 2020 08; 23(4):281-283. PMID: 32539623.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health